首页> 美国卫生研究院文献>BMC Palliative Care >Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study
【2h】

Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study

机译:连续静脉注射吗啡对晚期癌症患者血清和尿液中吗啡及吗啡代谢产物的浓度:一项观察性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe feasibility and clinical implication of drug monitoring of morphine, morphine-6-glucuronide (M6G) and morphine-3-glucuronide (M3G) need further investigation. This study aimed to determine what predicts serum concentrations of morphine in cancer patients receiving continuously intravenous morphine, the relationships between serum concentration of morphine/its metabolites and urinary concentrations, and the relation between morphine concentrations and with clinical outcomes.
机译:背景:吗啡,吗啡6-葡萄糖醛酸(M6G)和吗啡-3-葡萄糖醛酸(M3G)的药物监测的可行性和临床意义需要进一步研究。这项研究的目的是确定预测连续静脉注射吗啡的癌症患者的吗啡血清浓度,吗啡及其代谢产物的血清浓度与尿液浓度之间的关系,以及吗啡浓度与临床结局之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号